Tangentix Research
The sales you were going to get anyway
A practical framework for separating reported conversions from the demand an investment actually caused.
- Published
- July 10, 2026
- Reading time
- 4 minutes
- Author
- Tangentix Research
Executive decision brief
The conclusion, its use, and its boundary.
- Paper
- R / 001
- Evidence status
- Real methodology / anonymized evidence
Do not fund a channel from platform credit alone. Use converging counterfactual evidence, then let the lower credible effect set the funding boundary.
- Decision to settle
- How much reported return was actually earned?
- Decision output
- A scale, hold, reduce, or test rule tied to earned contribution rather than reported conversions.
- Claim boundary
- Anonymization removes the client context needed to reproduce a specific effect estimate.
Figure 01 / Evidence companion
The method, made inspectable.
Real methodology / anonymized evidence. The visual is paired with HTML interpretation so the argument does not depend on screenshot pixels.
Open evidence record Executive brief / TX-BRIEF-INC-01
- Artifact
- Executive brief
- Evidence status
- Real methodology / anonymized evidence
- Record ID
- TX-BRIEF-INC-01
- Record
- Sanitized client methodology / values withheld
- Decision question
- How much reported demand was earned rather than already likely?
A real anonymized methodology deliverable. Five independent analytical layers are combined before an incrementality recommendation is made.
Marketing reporting answers a familiar question: which touchpoint received credit? Incrementality asks the harder one: what would have happened without the investment?
Those questions are not interchangeable. A branded-search click can be correctly attributed to paid search and still represent a customer who was already navigating toward the brand. A retargeting impression can precede a purchase without causing it. The reported conversion is observable. The counterfactual is not.
The decision question
The useful question is not whether a channel participated in a sale. It is whether changing the investment changes the commercial outcome enough to justify the next dollar.
Incremental value = observed outcome − credible baseline outcome
The subtraction is simple. Establishing a credible baseline is the work.
A five-layer assessment
Tangentix does not treat one model or one test as conclusive. We look for convergence across five analytical layers.
- Cannibalization signature. Does paid exposure displace demand that would otherwise arrive through organic or direct routes?
- Market capture. When paid presence changes, does total category capture change—or only the credited channel?
- Competitive validity. Is the investment defending against real competitive pressure or bidding against the brand itself?
- Time-series response. Do changes in exposure precede a stable movement beyond seasonality and existing trend?
- Conversion quality. Are exposed and unexposed customers economically different after the transaction?
No layer proves causality alone. The recommendation becomes stronger when independent views point in the same direction and weaker when they conflict.
Choose the strongest feasible counterfactual
The best design depends on what the business can safely change.
- A randomized holdout is strongest when exposure can be controlled without unacceptable commercial risk.
- A geo experiment is useful when markets are comparable and contamination is limited.
- Difference-in-differences can work when a credible comparison group shares the pre-period trend.
- Interrupted time series can be informative when the intervention is distinct and the baseline is stable.
- Structural triangulation is appropriate when direct experimentation is not yet feasible, but its uncertainty must remain visible.
The method should follow the decision and operating constraints—not the other way around.
What changes after the analysis
An incrementality read should not end with a new attribution percentage. It should produce a funding boundary.
- Scale when the lower credible effect clears the commercial hurdle.
- Hold when the effect is plausible but uncertainty remains too wide.
- Reduce when reported return materially exceeds the supported incremental effect.
- Test when the cost of uncertainty is greater than the cost of creating better evidence.
The limitation that matters
Counterfactual estimates are conditional on design quality, data coverage, interference, and the stability of the baseline. A smaller result with an explicit uncertainty range is more decision-useful than a precise number built on assumptions nobody has surfaced.
The objective is not to make marketing look less effective. It is to identify the portion that genuinely earns the right to be funded again.
Evidence, limitations, and reproducibility.
- Revision
- 1.1
- Published
- July 10, 2026
- Last reviewed
- July 17, 2026
Evidence record
Use horizontal scrolling to inspect every source and its role in the argument.
Known limitations
- 01
Anonymization removes the client context needed to reproduce a specific effect estimate.
- 02
No single layer establishes causality; conflicting evidence must weaken the recommendation.
- 03
Counterfactual quality remains conditional on interference, data coverage, and baseline stability.
Primary sources behind the method.
These sources provide methodological context. Their inclusion does not imply that an external study validates Tangentix client outcomes or the illustrative evidence shown here.
- 01 Callaway, Brantly, and Pedro H. C. Sant'Anna. Difference-in-Differences with Multiple Time Periods. Journal of Econometrics 225(2), 2021.
Primary methodological reference for multi-period difference-in-differences, treatment-timing variation, and explicit identification assumptions.
- 02 Abadie, Alberto, Alexis Diamond, and Jens Hainmueller. Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California's Tobacco Control Program. Journal of the American Statistical Association 105(490), 2010, 493-505.
Primary reference for constructing a comparative counterfactual when one treated unit must be evaluated against a weighted donor pool.
What another analyst would need to preserve.
Document eligibility, exposure, outcome, pre-period trend, interference risks, model assumptions, and uncertainty; reproduce each analytical layer independently before evaluating convergence.
Applied method / Media Intelligence
Turn causal measurement into the next allocation rule.
A paper establishes the method and its limits. The applied system puts the method beside the accountable decision, working evidence, and release condition.
- Decision it informs
- How much reported return was actually earned?
- Working output
- Capital-allocation diagnostic record
- First evidence to inspect
- Spend, channel outcomes, finance baseline, prior tests, and operating constraints.
- Application boundary
- The method informs a decision only after the available evidence, counterfactual, and accountable owner have been checked.